These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6375339)

  • 61. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
    Verho M; Kirsten R; Bückert C
    Pharmatherapeutica; 1984; 3(9):595-606. PubMed ID: 6374680
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction.
    Little WC; Zile MR; Klein A; Appleton CP; Kitzman DW; Wesley-Farrington DJ
    Am J Cardiol; 2006 Aug; 98(3):383-5. PubMed ID: 16860028
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
    Pool PE; Seagren SC; Salel AF
    Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-acting diltiazem CD is safe and effective in a hypertensive Mexican-American population.
    Herrera CR; Lewin A; Fiddes R; Friedman J; Linn W; Baker T; Balanoff D; Beach CL
    Pharmacotherapy; 1997; 17(6):1254-9. PubMed ID: 9399608
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hemodynamic and neurohumoral factors in the response of hypertensives to hydrochlorothiazide therapy.
    Fernandez PG; Snedden W; Nath C; Vasdev S; Lee C; Darke A
    Clin Invest Med; 1987 Nov; 10(6):513-9. PubMed ID: 3326694
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of celiprolol on plasma renin, aldosterone, norepinephrine and epinephrine in primary hypertension.
    Kimura S; DeQuattro V; Hernandez PH; Lee DD
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):751-4. PubMed ID: 2971310
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
    Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The efficacy and tolerability of amlodipine and hydrochlorothiazide in Nigerians with essential hypertension.
    Ajayi AA; Akintomide AO
    J Natl Med Assoc; 1995 Jul; 87(7):485-8. PubMed ID: 7636894
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neurohormonal responses to antihypertensive treatment with captopril or hydrochlorothiazide.
    Rabinad E; Gaya J; Rivera F; Ingelmo M; Balcells A
    Postgrad Med J; 1986; 62 Suppl 1():143-5. PubMed ID: 3534850
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failure.
    Kulick DL; McIntosh N; Campese VM; Hsueh W; Rahimtoola SH; Massry SG; Elkayam U
    Am J Cardiol; 1987 May; 59(12):1138-43. PubMed ID: 3554952
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension.
    Szlachcic J; Tubau JF; Vollmer C; Massie BM
    Am J Cardiol; 1989 Jan; 63(3):198-201. PubMed ID: 2642633
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study.
    Grassi G; Seravalle G; Brambilla G; Dell'Oro R; Trevano FQ; Fici F; van Bortel L; Mancia G
    Adv Ther; 2017 Jan; 33(12):2173-2187. PubMed ID: 27771847
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.
    Massie B; MacCarthy EP; Ramanathan KB; Weiss RJ; Anderson M; Eidelson BA; Labreche DG; Tubau JF; Ulep D; Bartels D
    Ann Intern Med; 1987 Aug; 107(2):150-7. PubMed ID: 3300457
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension.
    Grossman E; Peleg E; Carroll J; Shamiss A; Rosenthal T
    Am J Hypertens; 1994 Dec; 7(12):1041-4. PubMed ID: 7702796
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.
    Muiesan G; Fariello R; Muiesan ML; Christensen OE
    Eur J Clin Pharmacol; 1985; 28(5):495-9. PubMed ID: 3899669
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V; Boccanelli A; Ewald S; Girerd X; Heagerty A; Krzesinski JM; Lins R; Rodicio J; Stefenelli T; Woittiez A; Böhm M
    Clin Drug Investig; 2007; 27(8):545-58. PubMed ID: 17638395
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.
    Rotmensch HH; Rocci ML; Vlasses PH; Swanson BN; Fedder IL; Soyka L; Ferguson RK
    Am J Cardiol; 1984 Aug; 54(3):353-6. PubMed ID: 6147080
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
    Ollivier JP; Wajman A; Stalla-Bourdillon A
    Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.